catechin has been researched along with Inflammatory Bowel Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fan, FY; Jiang, M; Sang, LX | 1 |
| Contreras, TC; Cremonini, E; Oteiza, PI; Ricciardi, E | 1 |
| Chen, Y; Lin, YZ; Song, YG | 1 |
1 review(s) available for catechin and Inflammatory Bowel Diseases
| Article | Year |
|---|---|
Catechins and Their Therapeutic Benefits to Inflammatory Bowel Disease.
Topics: Catechin; Cell Proliferation; Gastrointestinal Microbiome; Gene Expression Regulation; Humans; Inflammatory Bowel Diseases; Intercellular Junctions; Neutrophil Infiltration; Oxidative Stress | 2017 |
2 other study(ies) available for catechin and Inflammatory Bowel Diseases
| Article | Year |
|---|---|
(-)-Epicatechin in the prevention of tumor necrosis alpha-induced loss of Caco-2 cell barrier integrity.
Topics: Anti-Inflammatory Agents; Antioxidants; Biological Transport; Caco-2 Cells; Catechin; Cell Differentiation; Enzyme Activation; Epithelial Cells; Fluoresceins; Humans; Inflammatory Bowel Diseases; Intestinal Mucosa; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; NF-kappa B; Oxidants; Permeability; Tight Junctions; Tumor Necrosis Factor-alpha; Zonula Occludens-1 Protein | 2015 |
[Protective effect of epigallocatechin-3-gallate on inflammatory bowel disease: experiment with rat models of induced colitis].
Topics: Animals; Blotting, Western; Catechin; Cyclooxygenase 2; Disease Models, Animal; Gene Expression; Inflammatory Bowel Diseases; Intestinal Mucosa; Random Allocation; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Trinitrobenzenesulfonic Acid | 2007 |